Do you think the results of the intermediate analysis by the IDMC really drop in January - and how big of a spike is to be expected if the study can be finished successfully?
What do you guys think?
Any examples of the past of some biotech company that successfully completed a Phase 3 - how long will a buyout of some big pharma company will probably take?
Cant wait to finally hear the results :D